An official website of the United States government Here's how you know

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 204730
Company: GLENMARK PHARMS LTD

Products on ANDA 204730

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
FROVATRIPTAN SUCCINATE	FROVATRIPTAN SUCCINATE	EQ 2.5MG BASE	TABLET;ORAL	Prescription	AB	No	No

Approval Date(s) and History, Letters, Labels, Reviews for ANDA 204730

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
03/11/2016	ORIG-1	Approval				Label is not available on this site.

Supplements

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
10/24/2019	SUPPL-2	Labeling-Package Insert		Label is not available on this site.

Therapeutic Equivalents for ANDA 204730

FROVATRIPTAN SUCCINATE

TABLET;ORAL; EQ 2.5MG BASE
TE Code = AB

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
FROVATRIPTAN SUCCINATE	FROVATRIPTAN SUCCINATE	EQ 2.5MG BASE	TABLET;ORAL	Prescription	No	AB	211292	AMNEAL PHARMS CO
FROVATRIPTAN SUCCINATE	FROVATRIPTAN SUCCINATE	EQ 2.5MG BASE	TABLET;ORAL	Prescription	No	AB	204730	GLENMARK PHARMS LTD
FROVATRIPTAN SUCCINATE	FROVATRIPTAN SUCCINATE	EQ 2.5MG BASE	TABLET;ORAL	Prescription	No	AB	216998	LEADING
FROVATRIPTAN SUCCINATE	FROVATRIPTAN SUCCINATE	EQ 2.5MG BASE	TABLET;ORAL	Prescription	No	AB	213891	RENATA

Top